Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
about
Current approaches and challenges for monitoring treatment response in colon and rectal cancerColorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer.Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerationsHow reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis.Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer.Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.Adaptive radiation dose escalation in rectal adenocarcinoma: a review.18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis.A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer?The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.Role of three-dimensional anorectal ultrasonography in the assessment of rectal cancer after neoadjuvant radiochemotherapy: preliminary results.
P2860
Q27010257-E2E3C5C7-9551-42B6-94BD-CDA418978AA0Q34658635-78C2D1C8-3142-4E80-983F-D5FDAE78F742Q35106508-AF67A9D4-710F-49AA-9F26-FBC6F20F8B4CQ35552604-5719CDDE-C58C-4F6F-8B24-24FD7665A8F5Q36064592-D2BFF3DF-9B85-4818-8E38-EE16B2BB428FQ36343876-0D0EFB18-2396-470B-82E6-E724FD00CA2BQ36419166-8EA83901-EE50-4F43-96FA-3389F770D874Q36723979-C34F1C36-2377-4F1D-885D-CF4BFF08A506Q36984204-955D261F-96AA-4CD6-BC38-59F41FDDCE04Q37203529-51DCC9A4-C1FD-4C91-923B-872FA9B58F58Q37991239-7EAE38A1-E3F4-449B-914B-D99E9CFC324DQ37996935-F9E0D0D0-CDE0-4170-96C7-1F808FC6F62BQ41848836-305530BB-E4A8-4070-8F23-6A303FC8C153Q43262786-79A80588-E5DD-4DA0-B696-013B1B37210BQ43822307-7022CF68-F7C3-4916-8F93-52BC7C69A882Q45340414-DDA48954-65A5-47EF-BF47-13980753DF51Q45920677-5F60D1E8-4769-4AF8-ADA3-773C141A1B5FQ46322242-E7D48502-DE64-4685-8CFA-447E1F205908Q46581098-7A71EDAB-C333-4483-81A9-C445757A15AAQ53058913-237701CF-00B5-4F71-A1AA-398ADD69C26EQ53136323-37DD1660-AF7E-4314-B249-EE0BDE0D5EBEQ54407840-AED64A03-3ACD-480B-BB0B-4BFC66C65E38
P2860
Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Restaging after neoadjuvant ch ...... arcinoma: role of F18-FDG PET.
@en
Restaging after neoadjuvant ch ...... arcinoma: role of F18-FDG PET.
@nl
type
label
Restaging after neoadjuvant ch ...... arcinoma: role of F18-FDG PET.
@en
Restaging after neoadjuvant ch ...... arcinoma: role of F18-FDG PET.
@nl
prefLabel
Restaging after neoadjuvant ch ...... arcinoma: role of F18-FDG PET.
@en
Restaging after neoadjuvant ch ...... arcinoma: role of F18-FDG PET.
@nl
P2093
P1476
Restaging after neoadjuvant ch ...... arcinoma: role of F18-FDG PET.
@en
P2093
Andrea Nicolini
Angelo Carpi
Carlo Capirci
Cesare Polico
Domenico Rubello
Franca Chierichetti
Giorgio Crepaldi
Giovanni Mandoliti
P304
P356
10.1016/J.BIOPHA.2004.08.005
P577
2004-10-01T00:00:00Z